110 related articles for article (PubMed ID: 29097371)
1. Anti-CD19 resistance can "stem" from progenitors.
Shah NN; Fry TJ
Blood; 2017 Nov; 130(18):1961-1963. PubMed ID: 29097371
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD24 on CD19- CD79a+ early B-cell progenitors in human bone marrow.
Israel E; Kapelushnik J; Yermiahu T; Levi I; Yaniv I; Shpilberg O; Shubinsky G
Cell Immunol; 2005; 236(1-2):171-8. PubMed ID: 16181617
[TBL] [Abstract][Full Text] [Related]
3. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
Kitanaka A; Ito C; Coustan-Smith E; Campana D
J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
[TBL] [Abstract][Full Text] [Related]
4. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors.
Wolf ML; Weng WK; Stieglbauer KT; Shah N; LeBien TW
J Immunol; 1993 Jul; 151(1):138-48. PubMed ID: 7686930
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD19: the good, the bad, and CD81.
Velasquez MP; Gottschalk S
Blood; 2017 Jan; 129(1):9-10. PubMed ID: 28057672
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.
Panzer-Grümayer ER; Panzer S; Wolf M; Majdic O; Haas OA; Kersey JH
J Immunol; 1993 Jul; 151(1):92-9. PubMed ID: 7686950
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD34 on human B cell precursors.
Schmitt C; Eaves CJ; Lansdorp PM
Clin Exp Immunol; 1991 Jul; 85(1):168-73. PubMed ID: 1712682
[TBL] [Abstract][Full Text] [Related]
8. IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells.
Crooks GM; Hao QL; Petersen D; Barsky LW; Bockstoce D
J Immunol; 2000 Sep; 165(5):2382-9. PubMed ID: 10946261
[TBL] [Abstract][Full Text] [Related]
9. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel PG; Niethammer D; Handgretinger R
Klin Padiatr; 2005; 217(6):334-8. PubMed ID: 16307419
[TBL] [Abstract][Full Text] [Related]
10. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
Rickert RC; Rajewsky K; Roes J
Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
12. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
[TBL] [Abstract][Full Text] [Related]
13. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
15. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
17. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
18. Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors.
Ohkawara JI; Ikebuchi K; Fujihara M; Sato N; Hirayama F; Yamaguchi M; Mori KJ; Sekiguchi S
Leukemia; 1998 May; 12(5):764-71. PubMed ID: 9593276
[TBL] [Abstract][Full Text] [Related]
19. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.
Imai C; Mihara K; Andreansky M; Nicholson IC; Pui CH; Geiger TL; Campana D
Leukemia; 2004 Apr; 18(4):676-84. PubMed ID: 14961035
[TBL] [Abstract][Full Text] [Related]
20. CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.
Roifman CM; Ke S
Biochem Biophys Res Commun; 1993 Jul; 194(1):222-5. PubMed ID: 7687428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
